These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19089674)

  • 1. Vesicourethral dysfunction in multiple sclerosis. Initial assessment based on lower urinary tract symptoms and their pathophysiology.
    Di Benedetto P; Delneri C; Biasutti E; Bragadin LM; Giorgini T
    Neurol Sci; 2008 Dec; 29 Suppl 4():S348-51. PubMed ID: 19089674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urinary alterations in multiple sclerosis].
    Burguera-Hernández JA
    Rev Neurol; 2000 May 16-31; 30(10):989-92. PubMed ID: 10919202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vesicourethral dysfunction and urodynamic findings in multiple sclerosis: a study of 149 cases.
    Gallien P; Robineau S; Nicolas B; Le Bot MP; Brissot R; Verin M
    Arch Phys Med Rehabil; 1998 Mar; 79(3):255-7. PubMed ID: 9523775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapeutic management of lower urinary tract symptoms in Multiple Sclerosis patients.
    Zanghì A; Cimino S; Urzì D; Privitera S; Zagari F; Lanza G; Patti F; D'Amico E
    Expert Opin Pharmacother; 2020 Aug; 21(12):1449-1454. PubMed ID: 32452702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of lower urinary tract dysfunction in patients with multiple sclerosis. Committee of the European Study Group of SUDIMS (Sexual and Urological Disorders in Multiple Sclerosis).
    Fowler CJ; van Kerrebroeck PE; Nordenbo A; Van Poppel H
    J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):986-9. PubMed ID: 1469417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sacral neuromodulation: an effective treatment for lower urinary tract symptoms in multiple sclerosis.
    Puccini F; Bhide A; Elneil S; Digesu GA
    Int Urogynecol J; 2016 Mar; 27(3):347-54. PubMed ID: 26156206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uroneurological assessment of spina bifida cystica and occulta.
    Sakakibara R; Hattori T; Uchiyama T; Kamura K; Yamanishi T
    Neurourol Urodyn; 2003; 22(4):328-34. PubMed ID: 12808708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genitourinary changes in multiple sclerosis: the need for a urodynamic study].
    Martín C; Salinas J; Fernández-Durán A; Fernández-Gómez J; Jiménez N; Gangoiti L
    Rev Neurol; 2000 Apr 1-15; 30(7):643-8. PubMed ID: 10859743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association between neurologic involvement and lower urinary tract dysfunction and their symptoms in patients with multiple sclerosis].
    Zachoval R; Palascak P; Urban M; Zalesky M; Heracek J; Lukes M
    Prog Urol; 2003 Apr; 13(2):246-51. PubMed ID: 12765059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urological consequences of incomplete cord lesions in patients with myelomeningocele.
    Keshtgar AS; Rickwood AM
    Br J Urol; 1998 Aug; 82(2):258-60. PubMed ID: 9722763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vesicourethral dysfunction in multiple sclerosis.
    Blaivas JG; Bhimani G; Labib KB
    J Urol; 1979 Sep; 122(3):342-7. PubMed ID: 470006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower urinary tract symptoms in Parkinson's disease: Prevalence, aetiology and management.
    McDonald C; Winge K; Burn DJ
    Parkinsonism Relat Disord; 2017 Feb; 35():8-16. PubMed ID: 27865667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new comprehensive classification system for both lower and upper urinary tract dysfunction in patients with neurogenic bladder.
    Liao L
    Urol Int; 2015; 94(2):244-8. PubMed ID: 25115367
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of urinary tract infection and vesicoureteral reflux in children with lower urinary tract dysfunction.
    Van Batavia JP; Ahn JJ; Fast AM; Combs AJ; Glassberg KI
    J Urol; 2013 Oct; 190(4 Suppl):1495-9. PubMed ID: 23416636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EAU-ESPU guidelines recommendations for daytime lower urinary tract conditions in children.
    Tekgul S; Stein R; Bogaert G; Undre S; Nijman RJM; Quaedackers J; 't Hoen L; Kocvara R; Silay MS; Radmayr C; Dogan HS
    Eur J Pediatr; 2020 Jul; 179(7):1069-1077. PubMed ID: 32472266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Women with voiding dysfunction secondary to bladder outlet dyssynergia in the setting of multiple sclerosis do not demonstrate significantly elevated intravesical pressures.
    Lemack GE; Frohman E; Ramnarayan P
    Urology; 2007 May; 69(5):893-7. PubMed ID: 17482929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
    Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
    Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower urinary tract dysfunction in multiple sclerosis.
    Mayo ME; Chetner MP
    Urology; 1992 Jan; 39(1):67-70. PubMed ID: 1728799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of lower urinary tract symptoms in patients with idiopathic normal pressure hydrocephalus.
    Krzastek SC; Bruch WM; Robinson SP; Young HF; Klausner AP
    Neurourol Urodyn; 2017 Apr; 36(4):1167-1173. PubMed ID: 27490149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bladder and sphincter behavior in patients with spinal cord lesions.
    Kaplan SA; Chancellor MB; Blaivas JG
    J Urol; 1991 Jul; 146(1):113-7. PubMed ID: 2056568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.